Fin Cascade

Prices as of 8 Oct 2026 close · Not investment advice

PCBL Chemical Limited

NSE: PCBLCarbon Black

Share price

₹319.25

-2.34% close of 8 Oct 2026

Market cap ₹12,451 CrP/E 47.0

Business score

How strong the business is, in one number. The parts behind it are in Pro.

45

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹12,451 Cr

P/E ratio

47.0

P/B ratio

3.1

ROCE

7.8%

ROE

5.6%

Dividend yield

1.9%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹388.1552-week low ₹232.15

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 2.1% over the past year, and 11.3% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 14.2% to 12.9% over the last four years.

Whether it grew faster than its sector

It grew 11.3% a year against a sector median of 10.2% — 1.1 percentage points faster.

Room to re-rate, or risk of de-rating

At 47.0× earnings it costs 2.0× the market, which pays 23.9× across 2199 companies we can price. Its own industry sits at 56.2×, across 5 companies. It is against its own five-year median of 22.8×, the 92nd percentile of its own range.

Whether growth justifies the valuation

Its earnings are falling, so growth cannot justify the price.

Profit growthPrice per ₹1 profitPer 1% growth
PCBL Chemical Limited — this one-21%/yr47.0×—
Solar Industries India Limited30%/yr89.8×₹3.0
Pidilite Industries25%/yr56.2×₹2.2
SRF Limited-4%/yr32.9×—
Linde India Limited1%/yr93.8×₹93.8
Coromandel International Limited-1%/yr26.9×—

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies across the whole Chemicals sector, it ranks 123 of 182 on returns, 75 of 175 on growth, 73 of 182 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 7.8% on capital, ahead of 32% of companies across its whole sector. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹4235 crore of cash from the business and spent ₹3223 crore on plant and equipment, with ₹1012 crore to spare; it still raised ₹2513 crore mostly borrowed — borrowings rose from ₹786 crore to ₹4989 crore. And the profit is real: of every 100 rupees it reported over 12 years, about 198 arrived as cash — well above the profit; depreciation and interest are the reason, not a windfall. Its cash comes back faster than it used to: it went from being waiting 17 days for its cash to paid 40 days before it paid its own suppliers.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

8 of 9 checks clear · 89%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Profit grew 65% but carbon black volumes were flat against the high single-digit growth guided.

Announced 29 Jul 2026 · Consolidated

Revenue

₹2,473 Cr

Revenue vs last year

+17.0%

Revenue vs last quarter

+19.7%

Net profit

₹155 Cr

Profit vs last year

+64.8%

Profit vs last quarter

+287.3%

Net margin

6.3%

EPS

₹3.94

Earnings call transcript · 29 Jul 2026

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹12,451 Cr
Prev close
₹319.25
52w High
₹393
52w Low
₹227
Enterprise value
₹17,152 Cr
Beta
1.7
Price CAGR 1y
-16.0%
Price CAGR 3y
18.0%
Price CAGR 5y
21.0%
Price CAGR 10y
28.0%

Ratios

Return on assets
1.8%
PEG ratio
-2.3
P/E ratio
47.0
P/B ratio
3.1
EV / EBITDA
15.3
Industry P/E
22.1
ROCE
7.8%
ROCE 5y average
13.8%
ROE
5.6%
Debt / Equity
1.2
Interest coverage
1.6
Dividend yield
1.9%
ROE 3y average
11.0%
ROE last year
6.0%

Annual P&L

Annual revenue
₹8,189 Cr
Annual profit
₹198 Cr
Operating margin
13.0%
Net profit margin
2.4%
EBITDA margin
12.7%
Sales growth 3y
12.4%
Sales growth 5y
25.2%
Profit growth 3y
-21.0%
Profit growth 5y
-7.0%
EPS
₹5.0
Sales growth TTM
2.0%
Profit growth TTM
-36.0%
Dividend payout
119.0%

Quarter P&L

Sales latest quarter
₹2,473 Cr
Profit latest quarter
₹155 Cr
YoY quarterly sales growth
17.0%
YoY quarterly profit growth
64.9%
OPM latest quarter
16.0%

Balance Sheet

Book Value
₹103
Face Value
₹1.0
Total debt
₹4,989 Cr
Total cash
₹288 Cr
Borrowings
₹4,989 Cr
Reserves / Equity
101.7

Cash Flow

Operating cash flow
₹1,576 Cr
Free cash flow
₹851 Cr
FCF yield
3.4%
Net cash flow
-₹89 Cr

Shareholding

Promoter holding
53.4%
FII holding
5.8%
DII holding
11.3%
Public holding
28.4%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Himadri Special660.5541.733,3300.12228.426.31,431.928.022.1
PCBL Chemical321.4047.812,6461.90154.964.82,473.417.07.8
Median490.9744.822,9881.01191.745.51,952.622.514.9

Competes with: Himadri Speciality Chemical Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,3481,4871,6571,9292,1442,1632,0102,0872,1142,1641,8462,0662,473
Expenses1,1371,2491,3781,6191,7851,8001,6931,7901,7951,8971,6311,8232,078
Material Cost1,4541,4471,4971,3501,3801,767
Change in Inventories22-2.7528-6571-117
Purchases of Stock-in-Trade1.159.893.480.240.110.16
Employee Cost109109124116113130
Other Expenses204231244230259297
Operating Profit211238279310358364317298319266215243396
OPM %16161716171716141512121216
Other Income437231161120612-504
Exceptional items (within Other Income)000-21-4.190
Interest1921321081211191181031121071069793
Depreciation414853758486878892939494103
Profit before tax154172201149164164124126120781052204
Tax %29282626282525212221802324
Net Profit109123148111118123931009462240155
EPS in Rs2.893.253.922.953.133.272.472.652.491.630.051.023.94
Diluted EPS in Rs2.642.481.620.051.023.94

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,4701,8941,9272,5583,5293,2442,6604,4465,7746,4208,4048,1898,549
Expenses2,3191,7291,6622,1752,9122,7782,1433,7935,0435,3837,0677,1467,429
Material Cost5,8365,674
Change in Inventories-4431
Purchases of Stock-in-Trade1714
Employee Cost413463
Other Expenses845964
Operating Profit1511652653836164655176537311,0371,3371,0431,119
OPM %691415171419151316161313
Other Income14161223202819284137471412
Exceptional items (within Other Income)-0.52-25
Interest957251413746342953181461423403
Depreciation586261616692110121137217346373384
Profit before tax1247165304533355392532582676577261345
Tax %146658242819202024272524
Net Profit101669230383288314426442491435198259
EPS in Rs0.310.462.016.64118.319.10111213125.036.64
Diluted EPS in Rs115.13
Dividend Payout %3254301116423844474248119

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
16%
5 years
25%
3 years
12%
TTM
2%

Compounded profit growth

10 years
31%
5 years
-7%
3 years
-21%
TTM
-36%

Stock price CAGR

10 years
28%
5 years
21%
3 years
18%
1 year
-16%

Return on equity

10 years
14%
5 years
13%
3 years
11%
Last year
6%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital343434343434343838383839
Reserves4731,0101,0961,3431,6151,6651,9012,5762,7923,2093,6603,967
Borrowings1,2201,0227587177936177247861,0294,9835,5714,989
Other Liabilities2855246917769449951,0671,3851,5733,0662,4532,299
Minority Interest1213
Total Liabilities2,0122,5902,5802,8713,3873,3113,7264,7855,43311,29511,72211,295
Fixed Assets8511,4161,3881,3991,5001,6401,7421,9341,9686,8926,5957,128
CWIP808080671753062671751,130433732583
Investments86228291316362155196588234433516464
Other Assets9958678221,0901,3501,2101,5212,0872,1013,5373,8793,119
Total Assets2,0122,5902,5802,8713,3873,3113,7264,7855,43311,29511,72211,295

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity354223462932905323852905041,1057601,576
Cash from Investing Activity-68-121-36-34-278-107-203-541-552-4,214-690-675
Cash from Financing Activity34-262-337-110-70-389-180217-313,381-64-990
Net Cash Flow139-27148-58363-34-782726-89
Free Cash Flow238830619858301271-16-392573-4.36851

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days778488746866979170977862
Inventory Days5666726873541017048828065
Days Payable28741238881701341068014710092
Cash Conversion Cycle1057737546051645538325735
Working Capital Days-34-80-57-34-1-415174-11-24-40
ROCE %661117251617181714128

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters515151515151515151535353
FIIs7.077.126.685.294.995.245.585.536.085.685.565.79
DIIs7.786.255.616.416.806.708.939.8911101111
Government1.241.241.241.241.241.241.241.241.241.191.191.19
Public333435363635333231302928
No. of Shareholders1,88,6482,18,5242,41,4892,40,1622,77,3353,03,5312,92,5702,87,3292,85,5462,81,5842,84,4882,75,244

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -17.7% (₹388.10 → ₹319.25)Brick size ₹10.72 (fixed)Bricks 40
₹250₹300₹350₹319Nov '25Jan '26Mar '26May '26Jul '26Sep '26
Price moved up one brickPrice moved down one brickLast close ₹319.25 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

exports as % of revenue

81.00

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

4,701inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

4,13,04,074inr

2026-03-31

News

News and filings about PCBL Chemical Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Uses as raw material

  • Carbon Black Feedstock oil (CBFS/PFS/SFS)
  • Coal tar

Depends on the price of

  • Crude Oil Brent

Sells to

Buys from

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Carbon Black
Classification
Chemicals › Carbon Black
ISIN
INE602A01031

Business segments

  • Carbon Black · 78%
  • Chemical · 17%
  • Power · 4%

Plants

  • PCBL Chennai Carbon Black Plant
  • PCBL Durgapur Carbon Black Plant
  • PCBL Kochi Carbon Black Plant
  • PCBL Mundra Carbon Black Plant
  • PCBL Palej Carbon Black Plant

News impact

Big market events that reach PCBL Chemical Limited, and how the effect spreads.

23 Sept, 07:38 IST · Market event · medium impact

India starts anti-dumping probe into Chinese Glycine imports

India is probing cheap Chinese glycine imports, which could help home chemical makers later but may raise costs for food, drug and farm buyers if an import tax follows.

Chemicals

Who it hits first

  • India's trade investigator (DGTR, the body that checks unfair imports) opened a probe into cheap glycine, a simple chemical used in food, drugs and farm sprays, arriving from China.
  • If the probe finds harm to local makers, India can add an import tax (anti-dumping duty) that makes Chinese glycine costlier and helps home producers sell more.
  • No listed glycine maker is named in the evidence, so any stock lift today is hope of future protection, while buyers of glycine could later pay more.

Who may gain

  • Indian glycine and nearby specialty makers, if a duty lifts local prices (no single listed maker confirmed in the pack)
  • Farm-chemical sellers such as PI Industries and GSP Crop, if protection spreads to agro inputs

Along the supply chain

Downstream

Indian food, drug and farm-spray makers that buy glycine could face higher input costs if cheap Chinese supply is taxed.

Upstream

Chinese glycine exporters face the probe; if a duty follows, their shipments to India shrink.

Where demand moves

Business

No extra orders yet — the probe only starts the case; real business gain comes months later if a duty curbs Chinese supply and buyers switch to home makers.

Capital

No fresh funds flow; investors may bid up chemical shares on protection hopes, but cash gains arrive only if duties lift prices and profits.

How it spreads across sectors

Chemicals

Small positive mood for home makers on protection hopes; real gains only if a duty lands.

Pharma

Mild cost worry since glycine feeds drugs; dearer supply would squeeze pill makers later.

Textiles

Negligible near-term link; fibre makers watch only for broader China-duty mood.

A pattern seen before

Cascade chain

  • DGTR probes Chinese glycine dumping → possible import duty
  • Duty curbs cheap imports → domestic glycine prices firm
  • Chemical makers gain share → pharma and textile buyers face higher costs

Pattern name

China Cascade

Patterns

  • China Cascade

Sectors queried

  • Pharma
  • Textiles

When it plays out

Immediate

1–7 days: chemical shares drift on protection hopes with no order change.

Medium term

1–6 months: probe findings decide any duty; only then do prices, orders and margins move.

Short term

1–4 weeks: filings and hearing news set expectations; buyers watch for price hints.

15 Sept, 18:45 IST · Market event · medium impact

India, China start discussions on trade concerns

India and China have started fresh trade talks, but with nothing agreed yet no company gains or loses; chemical and metal makers face import risk while drug and electronics firms could gain cheaper inputs if deals follow.

ChemicalsHealthcareMetals & MiningTextiles

Who it hits first

  • India and China have started a fresh round of talks on trade concerns and supply chains, with more meetings expected. Nothing has been agreed or changed yet - no duties cut, no bans lifted, no orders signed - so no listed company gains or loses any business today. The companies most exposed if talks eventually change the rules are chemical makers facing Chinese imports, drug makers buying Chinese raw materials, metal makers watched for dumping, textile traders, and electronics firms using Chinese parts.

Who may gain

  • Nobody benefits yet - talks alone create no winners. If later rounds cut import friction, Indian buyers of Chinese inputs (drug makers needing bulk drugs, electronics assemblers needing parts) would pay less and earn more. If talks instead tighten protections, domestic chemical and metal makers shielded from Chinese goods would gain pricing power. Both paths are months away at best.

Along the supply chain

Downstream

Indian makers that consume Chinese inputs - drug formulators, electronics assemblers, pigment and dye users - could see lower input costs months from now if barriers fall; until then their supply and costs are unchanged.

Upstream

Chinese suppliers of raw materials (bulk drugs, electronic parts, specialty chemicals) could see steadier Indian demand if ties normalize, but no purchase-order changes until deals are signed.

Where demand moves

Business

No business demand moves yet: no buyer has new orders and no supplier has lost any, because the talks changed no rule. The path to watch is import policy - easier Chinese imports would shift orders from Indian chemical and carbon-black makers toward Chinese suppliers, while tighter rules would do the reverse.

Capital

No capital rotation is warranted on talks alone; money typically waits for duty or policy outcomes. At most, a light sympathy bid may touch large China-exposed importers, while domestic producers facing import risk may see mild caution selling - both likely to fade within days without follow-up news.

How it spreads across sectors

Chemicals

Pigment, dye and carbon-black makers compete directly with Chinese imports, so any easing of duties would squeeze their prices; no change yet.

Consumer Durables

Electronics assemblers using Chinese parts could gain cheaper inputs over time; gold jewellery has almost no China linkage.

Healthcare

Drug makers rely on Chinese bulk-drug imports, so smoother ties could slowly lower input costs; no change yet.

Metals & Mining

Steel and metal makers stay on dumping watch; talks could loosen or tighten the shield, direction unknown.

Textiles

Yarn and fabric trade flows both ways, so normalized ties are mildly helpful; nothing concrete yet.

A pattern seen before

Cascade chain

  • Talks reopen - no duty or policy change yet
  • Chemicals: pigment, dye and carbon-black makers face Chinese import risk if barriers ease
  • Healthcare: drug formulators could gain cheaper bulk-drug inputs over time
  • Metals & Mining: steel dumping watch stays either way
  • Textiles and electronics: two-way trade mildly helped by normalized ties

Pattern name

China Cascade

Sectors queried

  • Chemicals
  • Healthcare
  • Metals & Mining
  • Textiles
  • Consumer Durables

When it plays out

Immediate

In the next 1-7 days expect sentiment-only noise of about 1-2% on the most exposed names, fading fast without follow-up headlines.

Medium term

Over 1-6 months, if deals are struck, duty changes could move chemical, metal and drug stocks several percent; if talks stall, the story dies with no trace.

Short term

Over 1-4 weeks watch meeting readouts for any mention of duties, import curbs or market access - that is what would turn this story into real signals.

Who it hits first

  • Indian goods exporters to the US face a tariff overhang: pharma generics (AUROPHARMA, DRREDDY, SUNPHARMA), textiles/apparel & home textiles (WELSPUNLIV, GOKEX, KPRMILL), specialty/carbon-black chemicals (PCBL, ACI). IT services (TCS/INFY/HCLTECH/WIPRO) are largely exempt as tariffs apply to goods, not services.

Who may gain

  • Exporters domiciled in non-targeted countries and India's domestic-demand plays that do not ship goods to the US; India-UK FTA (in force) offers textile exporters a partial diversification offset.

Along the supply chain

Downstream

US retailers/distributors of Indian textiles and pharmacies dependent on Indian generics face higher landed costs and potential supply gaps.

Upstream

Indian cotton ginners/yarn spinners and API/intermediate suppliers to the exporters would see softer downstream order pull if US demand is curtailed.

Where demand moves

Business

If enacted, US importers substitute Indian goods (apparel, generics, carbon black) with suppliers from non-targeted countries, shifting order volumes away from Indian exporters; drug shortages could force partial US carve-outs that blunt the pharma hit.

Capital

Risk-off rotation out of US-export-heavy exporters (textiles, mid-cap chemicals) toward domestic-consumption and rate-sensitive names insulated from US trade; quality large-cap IT (cheap, services-exempt) acts as a relative safe harbour within the export basket.

How it spreads across sectors

Chemicals

US-export chemical margin risk

IT Services

indirect sentiment/rupee only — no direct goods levy

Pharma

US-generics margin/volume risk if enacted (exemptions likely)

Textiles

US apparel/home-textile order risk, partly offset by UK FTA

codex additions

  • Oil Refining and Marketing
  • Aviation
  • Paints, Tyres and Plastic Products
  • Ports, Shipping and Logistics
  • Banks and Trade Finance
  • Metals, Engineering and Capital Goods Exporters
  • Seafood, Rice, Spices and Agri Exports
  • Packaging and Paper
  • Defence and Strategic Manufacturing

When it plays out

Immediate

Shallow, mean-reverting risk-off dip in export-heavy names on headline risk (as on 2025-08-05)

Medium term

Outcome hinges on enactment + presidential waiver and whether India curbs Russian crude; product carve-outs likely for essential drugs

Short term

Direct goods exporters (textiles, carbon black) stay pressured while the bill's passage and waiver stance are debated

Other sectors it reaches

  • {"causal_chain":"Tariff threat is tied to Russian crude purchases -\u003e policy pressure to cut Russian crude share -\u003e loss of discounted crude feedstock and more expensive sourcing from Middle East/US -\u003e weaker refining/marketing margins and possible fuel-price policy friction.","direction":"negative","example_tickers":["RELIANCE","IOC","BPCL"],"magnitude":"large","notes":"Most exposed if India materially reduces Russian barrels; impact partly offset if refiners can pass through higher costs. [Codex Layer 5.5]","sector":"Oil Refining and Marketing","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Reduced Russian crude discounts or higher crude risk premium -\u003e higher ATF costs -\u003e margin pressure for airlines, especially if fares cannot fully adjust during weak demand periods.","direction":"negative","example_tickers":["INDIGO","SPICEJET"],"magnitude":"medium","notes":"Fuel is a major airline cost; direction depends on crude move and fare discipline. [Codex Layer 5.5]","sector":"Aviation","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Crude-linked input basket rises if India loses discounted crude advantage -\u003e petrochemical derivatives, rubber, solvents and packaging costs increase -\u003e gross margin pressure for downstream manufacturers.","direction":"negative","example_tickers":["ASIANPAINT","BERGEPAINT","APOLLOTYRE"],"magnitude":"medium","notes":"Companies with pricing power may recover margins with a lag. [Codex Layer 5.5]","sector":"Paints, Tyres and Plastic Products","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Tariff uncertainty -\u003e lower US-bound goods volumes in textiles, chemicals, auto parts and pharma -\u003e reduced container throughput and freight activity; crude sourcing shifts could also alter tanker route economics.","direction":"mixed","example_tickers":["ADANIPORTS","CONCOR","BLUEDART"],"magnitude":"medium","notes":"Container/export logistics negative; crude-routing changes may create pockets of offsetting activity. [Codex Layer 5.5]","sector":"Ports, Shipping and Logistics","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Exporters face order deferrals, receivable delays and inventory buildup -\u003e higher working-capital needs and credit risk -\u003e pressure on lenders with MSME/exporter exposure and trade-finance books.","direction":"negative","example_tickers":["SBIN","AXISBANK","FEDERALBNK"],"magnitude":"small","notes":"Systemic impact likely limited unless tariffs are enacted and sustained. [Codex Layer 5.5]","sector":"Banks and Trade Finance","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Broad tariff threat on Indian goods -\u003e US buyers may delay sourcing decisions beyond listed sectors -\u003e pressure on engineering goods, industrial components and metal product exports.","direction":"negative","example_tickers":["HINDALCO","APLAPOLLO","BHEL"],"magnitude":"medium","notes":"More relevant for companies with direct or indirect US goods exposure. [Codex Layer 5.5]","sector":"Metals, Engineering and Capital Goods Exporters","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Tariffs on Indian goods would hit price-sensitive food exports -\u003e US importers switch to Vietnam, Thailand, Ecuador or other suppliers -\u003e demand and margin pressure on Indian agri/food exporters.","direction":"negative","example_tickers":["AVANTIFEED","KRBL","LTFOODS"],"magnitude":"medium","notes":"Seafood and specialty food exports can be highly tariff-sensitive. [Codex Layer 5.5]","sector":"Seafood, Rice, Spices and Agri Exports","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Export slowdown in textiles, pharma, chemicals, food and consumer goods -\u003e lower demand for cartons, labels, flexible packaging and export-grade packaging materials.","direction":"negative","example_tickers":["UFLEX","TCPLPACK","JKPAPER"],"magnitude":"small","notes":"Second-order volume impact; domestic demand cushions downside. [Codex Layer 5.5]","sector":"Packaging and Paper","time_horizon":"1_to_6_months"}
  • {"causal_chain":"US-India trade friction over Russia ties -\u003e risk of slower strategic cooperation, procurement clearances or technology-transfer sentiment -\u003e uncertainty for defence and aerospace supply-chain names.","direction":"mixed","example_tickers":["HAL","BEL","BDL"],"magnitude":"small","notes":"Negative if diplomatic friction deepens; positive if India accelerates domestic indigenisation. [Codex Layer 5.5]","sector":"Defence and Strategic Manufacturing","time_horizon":"1_to_6_months"}

Who it hits first

  • Export-oriented manufacturers in Textiles, Chemicals and Engineering/Capital Goods could see a sentiment lift on hopes of fresh export incentives; no concrete measure is announced — the July 3 meeting is a consultation.

Who may gain

  • High export-revenue chemical exporters PCBL (81% export revenue, carbon black) and ACI (79% export revenue, marine specialty chemicals)

Along the supply chain

Downstream

Global tyre manufacturers (PCBL carbon black) and overseas specialty-chemical buyers (ACI bromine, industrial salt) are the export customers; export facilitation could ease their order flow but nothing changes until concrete measures are notified.

Upstream

Carbon-black feedstock (CBFS) suppliers to PCBL and bromine/marine-chemical input providers to ACI would see higher offtake only if export volumes actually rise after an incentive; a consultation produces no immediate change.

Where demand moves

Business

A concrete export incentive would route incremental external demand to high-export-share manufacturers (PCBL ~81%, ACI ~79%) via better price realisation and duty drawback; lower-export-share peers benefit proportionally less. Until a measure lands, business demand is unchanged.

Capital

Sentiment-driven rotation into export-themed mid-cap manufacturing (Textiles, Chemicals, Capital Goods) on incentive hopes; the flow reverses if the July 3 meeting yields no concrete measure.

How it spreads across sectors

Capital Goods

Positive on engineering-goods export-promotion focus

Chemicals

Positive — high-export chemical names are direct read-throughs

Textiles

Positive on hopes of export incentives (RoDTEP, interest equalisation) for a labour-intensive export sector

codex additions

When it plays out

Immediate

Mild positive sentiment for high-export names ahead of the July 3 meeting; no earnings change

Medium term

Only a notified, funded incentive with clear eligibility and pass-through would translate into actual margin/order uplift for export-oriented manufacturers

Short term

Reaction hinges on whether the July 3 meeting yields concrete measures (RoDTEP enhancement, freight/interest subsidy); absent specifics, sentiment fades

Other sectors it reaches

  • {"causal_chain":"Export-boost consultation could include faster clearances, market-access support, logistics relief or incentive continuity for high-value regulated exports; pharma and API exporters benefit from lower friction and improved policy visibility.","direction":"positive","example_tickers":["SUNPHARMA","CIPLA","DIVISLAB"],"magnitude":"medium","notes":"Benefit is sentiment-led unless specific measures address regulated-market approvals, APIs or freight costs.","sector":"Pharmaceuticals \u0026 APIs","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"A broad export-promotion agenda may extend beyond goods to services exports; any signals on tax clarity, SEZ/GIFT City facilitation, skilling or global market access can support IT and business-service exporters.","direction":"positive","example_tickers":["TCS","INFY","HCLTECH"],"magnitude":"small","notes":"Less direct than manufacturing because the meeting framing often focuses on merchandise exports.","sector":"IT Services","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Export push typically raises focus on port efficiency, freight subsidies, customs digitisation and trade corridors; higher export volumes or lower turnaround bottlenecks can lift logistics and port operators.","direction":"positive","example_tickers":["ADANIPORTS","CONCOR","BLUEDART"],"magnitude":"medium","notes":"Upside depends on whether policy measures target freight cost, container availability or port dwell times.","sector":"Logistics, Ports \u0026 Shipping","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Gems and jewellery are major export categories; measures on duty drawback, trade financing, gold import procedures or market promotion could improve margins and order visibility.","direction":"positive","example_tickers":["TITAN","KALYANKJIL","SENCO"],"magnitude":"medium","notes":"Listed pure-play export exposure is limited; many large exporters are unlisted, so ticker mapping is imperfect.","sector":"Gems \u0026 Jewellery","time_horizon":"1_to_4_weeks"}
  • {"causal_chain":"Engineering export support can spill into auto ancillaries through incentives for component exports, quality certification support, FTAs and lower logistics costs; global OEM supply-chain diversification also amplifies the link.","direction":"positive","example_tickers":["MOTHERSON","BOSCHLTD","BHARATFORG"],"magnitude":"medium","notes":"More relevant for companies with sizeable overseas revenue or export-oriented component lines.","sector":"Auto Components","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Export-growth policy may prioritize electronics as a strategic category; faster customs, component ecosystem support, PLI alignment or export-credit measures can aid EMS and consumer-electronics supply chains.","direction":"positive","example_tickers":["DIXON","KAYNES","SYRMA"],"magnitude":"medium","notes":"Potentially large if the discussion leads to concrete electronics-export facilitation, but consultation alone is only a sentiment trigger.","sector":"Electronics Manufacturing \u0026 EMS","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Export incentives often involve interest equalisation, working-capital support, export credit insurance and forex services; banks with strong SME/exporter books may see incremental credit demand and fee income.","direction":"mixed","example_tickers":["SBIN","HDFCBANK","ICICIBANK"],"magnitude":"small","notes":"Positive from credit demand and fees, but subsidised lending or directed-credit schemes can limit margin upside.","sector":"Banks \u0026 Trade Finance","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Higher export volumes in textiles, pharma, chemicals, food and consumer goods increase demand for cartons, labels, flexible packaging and compliant export-grade materials.","direction":"positive","example_tickers":["UFLEX","TCPLPACK","JKPAPER"],"magnitude":"small","notes":"Second-order volume benefit; commodity input costs can offset margin gains.","sector":"Packaging \u0026 Paper","time_horizon":"1_to_6_months"}
  • {"causal_chain":"Export-promotion measures may target processed foods, marine products, rice, spices and value-added agriculture through market access, certification support and cold-chain logistics.","direction":"positive","example_tickers":["LTFOODS","KRBL","AVANTIFEED"],"magnitude":"medium","notes":"Policy details matter because agri exports are also exposed to domestic price-control and export-restriction risk.","sector":"Food Processing \u0026 Agri Exports","time_horizon":"1_to_6_months"}

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

4 Aug 2026interim₹4.5
27 Oct 2025interim₹6
16 Jan 2025interim₹5.5
29 Jan 2024interim₹5.5
10 Feb 2023interim₹5.5
11 Apr 2022split₹0
1 Feb 2022interim₹10
1 Feb 2021interim₹7

Splits, bonuses & buybacks

  • daily-prices repair: 8 rows from NSE's archive (replace 2, delete 1, insert 5), 2023-11-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Nov 2023

Bulk & block deals

DateWhoBought / soldSharesPrice
29 Jul 2026MICROCURVES TRADING PRIVATE LIMITEDBUY19,70,820₹358.98
29 Jul 2026MICROCURVES TRADING PRIVATE LIMITEDSELL19,70,820₹359.24

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.